Research Article

Expression Profiling of Genes Related to Endothelial Cells Biology in Patients with Type 2 Diabetes and Patients with Prediabetes

Table 2

Genes with altered expression in group 1 and group 2 comparing to group 3.

SymbolDescriptionT2DMPrediabetes
Fold changes95% CIFold changes95% CI

ACEAngiotensin I converting enzyme1.69(0.95, 2.43)
ADAM17ADAM metallopeptidase domain 171.788(0.00001, 3.93)1.5804(1.01, 2.15)
AGTAngiotensinogen (serpin peptidase inhibitor, clade A, member 8)1.8188(1.16, 2.47)
ALOX5Arachidonate 5-lipoxygenase3.6158(1.93, 5.30)2.1048(1.33, 2.88)
ANGPT1Angiopoietin 12.3495(1.29, 3.41)
ANXA5Annexin A52.5639(1.79, 3.34)1.8502(1.16, 2.54)
APOEApolipoprotein E3.2588(1.76, 4.76)
BAXBCL2-associated X protein2.5497(1.69, 3.41)1.883(1.21, 2.56)
BCL2B-cell CLL/lymphoma 22.0567(1.29, 2.82)1.6294(1.03, 2.23)
BCL2L1BCL2-like 11.8493(0.67, 3.03)
CALCACalcitonin-related polypeptide alpha2.6938(1.51, 3.88)1.8562(1.17, 2.55)
CASP1Caspase 1, apoptosis-related cysteine peptidase2.3823(1.62, 3.14)2.2207(1.41, 3.04)
CASP3Caspase 3, apoptosis-related cysteine peptidase2.9032(0.00001, 6.08)2.8474(0.00001, 5.98)
CCL2Chemokine (C-C motif) ligand 21.7255(0.68, 2.77)
CCL5Chemokine (C-C motif) ligand 50.6962(0.52, 0.87)
CDH5Cadherin 5, type 2 (vascular endothelium)3.4734(1.53, 5.42)
CFLARCASP8 and FADD-like apoptosis regulator2.3999(1.33, 3.47)1.5695(0.74, 2.40)
COL18A1Collagen, type XVIII, alpha 12.4144(0.85, 3.98)2.171(1.13, 3.21)
CX3CL1Chemokine (C-X3-C motif) ligand 14.2901(2.08, 6.50)2.816(1.23, 4.41)
EDN1Endothelin 11.8622(1.11, 2.62)1.5294(0.78, 2.28)
EDN2Endothelin 22.456(0.41, 4.50)1.3964(0.96, 1.84)
EDNRAEndothelin receptor type A1.9702(0.81, 3.13)
ENGEndoglin1.9575(1.25, 2.66)
F2RCoagulation factor II (thrombin) receptor2.1302(1.16, 3.10)
F3Coagulation factor III (thromboplastin, tissue factor)2.7747(1.53, 4.02)1.9368(0.94, 2.93)
FASFas (TNF receptor superfamily, member 6)2.4166(1.17, 3.66)
FASLGFas ligand (TNF superfamily, member 6)1.6629(1.03, 2.30)
FGF1Fibroblast growth factor 1 (acidic)0.7285(0.59, 0.87)
FLT1Fms-related tyrosine kinase 12.177(1.54, 2.81)1.4185(0.99, 1.84)
FN1Fibronectin 148.4245(0.00001, 105.64)3.0987(1.00, 5.20)
ICAM1Intercellular adhesion molecule 11.8786(1.17, 2.58)
IL11Interleukin 112.1411(1.31, 2.97)
IL1BInterleukin 1, beta2.9739(1.87, 4.08)1.8899(1.24, 2.54)
IL3Interleukin 3 (colony-stimulating factor, multiple)176.599(0.00001, 474.01)2.4413(1.44, 3.44)
IL6Interleukin 6 (interferon, beta 2)1.6806(0.97, 2.39)
IL7Interleukin 71.3835(0.71, 2.06)
ITGA5Integrin, alpha 5 (fibronectin receptor, alpha polypeptide)2.6864(1.61, 3.76)1.8891(1.19, 2.59)
ITGAVIntegrin, alpha V (vitronectin receptor, alpha polypeptide, antigen CD51)1.7913(1.17, 2.41)1.6077(1.00, 2.21)
ITGB1Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 including MDF2, MSK12)1.9693(1.44, 2.49)1.6144(0.98, 2.24)
ITGB3Integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61)4.9899(2.90, 7.08)2.5427(0.65, 4.43)
KDRKinase insert domain receptor (a type III receptor tyrosine kinase)1.6884(0.78, 2.59)
KITV-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog1.6025(0.89, 2.31)1.6211(1.07, 2.18)
MMP1Matrix metallopeptidase 112.8082(3.18, 22.43)
MMP2Matrix metallopeptidase 22.6715(0.87, 4.47)1.7691(1.13, 2.41)
MMP9Matrix metallopeptidase 94.4005(2.21, 6.60)
NOS3Nitric oxide synthase 3 (endothelial cell)2.5532(1.62, 3.48)
PECAM1Platelet/endothelial cell adhesion molecule0.5887(0.35, 0.82)0.2377(0.14, 0.33)
PF4Platelet factor 41.397(0.62, 2.17)
PGFPlacental growth factor2.9547(1.87, 4.04)2.2258(1.21, 3.24)
PLATPlasminogen activator, tissue1.788(1.03, 2.55)2.0088(1.03, 2.99)
PLAUPlasminogen activator, urokinase7.8263(2.73, 12.93)3.6782(1.53, 5.83)
PLGPlasminogen3.8718(1.36, 6.38)2.18(0.52, 3.84)
PROCRProtein C receptor, endothelial1.7096(1.08, 2.34)
PTGISProstaglandin I2 (prostacyclin) synthase2.18(1.22, 3.14)
PTGS2Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)2.5639(1.08, 4.05)2.0312(1.25, 2.81)
PTK2PTK2 protein tyrosine kinase 21.7263(0.84, 2.62)
SELESelectin E1.8021(0.90, 2.70)2.3075(1.17, 3.44)
SELLSelectin L2.4044(1.58, 3.22)1.6476(1.16, 2.13)
SELPLGSelectin P ligand2.42(1.80, 3.04)2.0023(1.37, 2.64)
SERPINE1Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 13.2035(1.87, 4.53)2.0463(1.12, 2.97)
SOD1Superoxide dismutase 1, soluble0.6517(0.46, 0.84)0.5267(0.33, 0.73)
SPHK1Sphingosine kinase 12.2258(1.35, 3.10)1.6339(0.65, 2.62)
TEKTEK tyrosine kinase, endothelial2.2454(1.29, 3.20)
TFPITissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor)1.4959(0.95, 2.04)
TGFB1Transforming growth factor, beta 12.8056(1.88, 3.73)3.142(1.70, 4.58)
THBDThrombomodulin3.685(2.00, 5.37)2.0097(1.20, 2.82)
THBS1Thrombospondin 11.8588(1.18, 2.54)1.433(0.75, 2.12)
TIMP1TIMP metallopeptidase inhibitor 12.6814(1.82, 3.54)3.283(1.82, 4.74)
TNFTumor necrosis factor1.5922(1.11, 2.07)
TNFSF10Tumor necrosis factor (ligand) superfamily, member 101.5084(1.07, 1.94)
TYMPThymidine phosphorylase2.9739(1.01, 4.93)
VEGFAVascular endothelial growth factor A2.0406(1.44, 2.64)
VWFVon Willebrand factor2.035(1.41, 2.66)1.6226(0.92, 2.32)

Group 1: T2DM patients; group 2: patients with prediabetes; group 3: control group.
95% confidence interval.